Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company expects revenues in 2012 to exceed $10M .
Revenues will be derived from the licensing of Medisafe 1 Technology's patented locking devices on syringes and the licensing of the related Bar-Code Pre-Matching safety device software application .The patent is also applicable to intravenous infusion and transfusion bags.
Discussions for licensing the technology devices are already underway in Israel, where the technology is expected to eventually be implemented across the State's nationwide medical system.
Medisafe 1 Technologies is currently attempting to enter into additional markets for its lifesaving technologies.
"Many reputable organizations and companies have expressed the value they recognize in our technologies," said, Jacob Elhadad, CEO of Medisafe 1 Technologies. "Through the further development of existing marketing channels, and the mass production of our licensed products, we expect reporting revenues in 2012 to exceed $10 million."
Medisafe 1 Technologies Corp.